Skip to main content
. 2001 Feb;123(2):271–279. doi: 10.1046/j.1365-2249.2001.01391.x

Fig. 4.

Fig. 4

(a) Changes in the serum levels of IP-10 in autoimmune hepatitis (AIH) patients who received prednisolone therapy (n = 14). Before therapy, before prednisolone therapy; after resolution, after successful prednisolone therapy. (b) Changes in the serum levels of IP-10 in chronic hepatitis C (CHC) patients who showed complete response to the IFN therapy (n = 24). Before IFN, before IFN therapy; 3 M after IFN, 3 months after the completion of IFN therapy; 12 M after IFN, 12 months after the completion of IFN therapy. *P < 0·0001.